iPS Research For Parkinson’s Disease Advances
This article was originally published in PharmAsia News
An iPS research group at Kyoto University has succeeded in creating nerve cells from iPS cells to improve the symptoms of Parkinson’s disease in an experiment on mice.
You may also be interested in...
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.
Sanofi follows Janssen in teaming up with HHS' BARDA to develop a COVID-19 vaccine; using technology platform of its Flublok vaccine, Sanofi expects to enter clinical trials in 1 to 1 ½ years.
Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV therapy or prevention with broadly neutralizing antibodies discovered by Rockefeller U.